source
- GSK partners with Engitix on multi-target liver researchGSK announced a collaboration with London-based Engitix to explore multiple targets for liver disease. Engitix will apply its extracellular matrix-based disease models to uncover new therapeutic op…
- Cavalry Biosciences seeks $75M Series B to advance eye and muscle disorder candidatesCavalry Biosciences, the first company emerging from the Jupiter Bioventures incubator, announced it is pursuing a $75 million Series B financing round. The capital is intended to move its first t…